Royal Bank of Canada’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-893
Closed -$4K 7303
2023
Q2
$4K Buy
893
+143
+19% +$640 ﹤0.01% 6734
2023
Q1
$1K Hold
750
﹤0.01% 6896
2022
Q4
$2K Hold
750
﹤0.01% 6930
2022
Q3
$2K Hold
750
﹤0.01% 7024
2022
Q2
$1K Buy
+750
New +$1.14K ﹤0.01% 7134
2021
Q4
Sell
-776
Closed -$2K 7767
2021
Q3
$2K Buy
+776
New +$2.04K ﹤0.01% 7342
2021
Q1
Sell
-519
Closed -$3K 7540
2020
Q4
$3K Buy
519
+428
+470% +$1.93K ﹤0.01% 6796
2020
Q3
$0 Buy
+91
New +$419 ﹤0.01% 6758
2018
Q2
Sell
-3
Closed 6632
2018
Q1
$0 Buy
+3
New +$79 ﹤0.01% 6541

Other funds holding IFRX

Royal Bank of Canada's IFRX Position: Q3 2023 in Review

Royal Bank of Canada sold out of InflaRx (IFRX) in Q3 2023, closing a stake of 893 shares — an estimated $4K sold.

Royal Bank of Canada first reported a position in IFRX in Q1 2018 and held it in 9 quarters. The position peaked at $4K in Q2 2023. 42 funds tracked by Wall St. Rank hold IFRX as of Q3 2023.

  • Royal Bank of Canada reported no remaining InflaRx position as of Q3 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 893 InflaRx shares in Q3 2023, an estimated $4K.
  • Royal Bank of Canada first reported a position in InflaRx in Q1 2018 and held it in 9 quarters.
  • Royal Bank of Canada's InflaRx position peaked at $4K in Q2 2023.
  • 42 funds tracked by Wall St. Rank held InflaRx as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.